Proteomic and Metabolomic Characterization of COVID-19 Patient Sera

ABSTRACT: Early detection and effective treatment of severe COVID-19 patients remain major challenges. Here, we performed proteomic and metabolomic profiling of sera from 46 COVID-19 and 53 control individuals. We then trained a machine learning model using proteomic and metabolomic measurements from a training cohort of 18 non-severe and 13 severe patients. The model was validated using ten independent patients, seven of which were correctly classified. Targeted proteomics and metabolomics assays were employed to further validate this molecular classifier in a second test cohort of 19 new COVID-19 patients, leading to 16 correct assignments. We identified molecular changes in the sera of COVID-19 patients compared to other groups implicating dysregulation of macrophage, platelet degranulation and complement system pathways, and massive metabolic suppression. This study revealed characteristic protein and metabolite changes in the sera of severe COVID-19 patients, which might be used in selection of potential blood biomarkers for severity evaluation.

• Dataset imported into MassIVE from https://www.iprox.org/page/project.html?id=IPX0002106000 on 05/29/20

INSTRUMENT(S): Q Exactive HF

ORGANISM(S): Severe Acute Respiratory Syndrome Coronavirus 2 (ncbitaxon:2697049) Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Tiannan Guo  

PROVIDER: MSV000085507 | MassIVE | Fri May 29 15:11:00 BST 2020

SECONDARY ACCESSION(S): PXD019221

REPOSITORIES: MassIVE